We are live on ! Find out more
ETRM

EnteroMedics Inc.
ETRM

Delisted

ETRM was delisted on the 20th of October, 2017.

Back to rankings

50 hedge funds and large institutions have $45.9M invested in EnteroMedics Inc. in 2013 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 11 increasing their positions, 10 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

666% more call options, than puts

Call options by funds: $1.33M | Put options by funds: $174K

100% more capital invested

Capital invested by funds: $23M → $45.9M (+$22.9M)

89% more first-time investments, than exits

New positions opened: 17 | Existing positions closed: 9

19% more funds holding

Funds holding: 42 → 50 (+8)

10% more repeat investments, than reductions

Existing positions increased: 11 | Existing positions reduced: 10

Holders
50
Holders Change
+8
Holders Change %
+19.05%
% of All Funds
1.45%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
17
Increased
11
Reduced
10
Closed
9
Calls
$1.33M
Puts
$174K
Net Calls
+$1.16M
Net Calls Change
+$1.15M

Top Buyers

Rank Fund Capital Flow
1
RA
Royce & Associates
New York
+$1.92M
2
PGCM
Prescott Group Capital Management
Oklahoma
+$964K
3
AAP
Ardsley Advisory Partners
Connecticut
+$845K
4
CCM
Coe Capital Management
Illinois
+$345K
5
Jacobs Levy Equity Management
Jacobs Levy Equity Management
New Jersey
+$318K

Top Sellers

Rank Fund Capital Flow
1
Wells Fargo
Wells Fargo
California
-$625K
2
Renaissance Technologies
Renaissance Technologies
New York
-$382K
3
Millennium Management
Millennium Management
New York
-$259K
4
MHP
Manatuck Hill Partners
Connecticut
-$249K
5
VKH
Virtu KCG Holdings
New York
-$198K
Name Holding Trade Value Shares
Change 		Change in
Stake
TD Asset Management
26
TD Asset Management
Ontario, Canada
$151K – – –
Northern Trust
27
Northern Trust
Illinois
$134K -$12.9K -8 -11%
DWT
28
Dorsey & Whitney Trust
South Dakota
$127K – – –
Bank of Montreal
29
Bank of Montreal
Ontario, Canada
$102K +$77.4K +48 New
Nomura Holdings
30
Nomura Holdings
Japan
$83K -$35.5K -22 -36%
EA
31
Emerald Advisers
Pennsylvania
$71K +$53.2K +33 New
Millennium Management
32
Millennium Management
New York
$61K -$259K -161 -85%
Susquehanna International Group
33
Susquehanna International Group
Pennsylvania
$44K -$70.9K -44 -69%
MAA
34
Managed Account Advisors
New Jersey
$35K -$17.7K -11 -41%
State Street
35
State Street
Massachusetts
$29K – – –
GC
36
Guggenheim Capital
Illinois
$28K +$1.61K +1 +8%
Cambridge Investment Research Advisors
37
Cambridge Investment Research Advisors
Iowa
$28K +$21K +13 New
Two Sigma Investments
38
Two Sigma Investments
New York
$23K +$17.7K +11 New
Morgan Stanley
39
Morgan Stanley
New York
$20K -$4.83K -3 -25%
CCA
40
Conestoga Capital Advisors
Pennsylvania
$20K – – –
Dimensional Fund Advisors
41
Dimensional Fund Advisors
Texas
$11K – – –
PFO
42
Pathstone Family Office
New Jersey
$5K +$3.22K +2 New
BNP Paribas Financial Markets
43
BNP Paribas Financial Markets
France
$4.79K +$3.22K +2 New
PRCM
44
Pine River Capital Management
Minnesota
$4K +$17.7K +11 New
Ameriprise
45
Ameriprise
Minnesota
$3K – – –
AIG
46
American International Group
New York
$2.04K – – –
Royal Bank of Canada
47
Royal Bank of Canada
Ontario, Canada
$2K – – –
JG
48
Jefferies Group
New York
$2K +$1.61K +1 New
Citigroup
49
Citigroup
New York
$1K -$4.83K -3 -75%
Goldman Sachs
50
Goldman Sachs
New York
$1K – – –
1
2
3

ETRM Hedge Fund Activity: Q4 2013 in Review

50 of the 3,445 institutional investors tracked by Wall St. Rank reported a position in EnteroMedics Inc. (ETRM) for Q4 2013, worth a combined $45.9M — up 100% from $23M a quarter earlier.

Buyers outnumbered sellers: 17 funds opened new ETRM positions and 9 closed out — a net gain of 8 holders — while 11 added to existing stakes and 10 trimmed.

The largest buyer was Royce & Associates, adding an estimated $1.92M. The largest seller was Wells Fargo, cutting an estimated $625K.

  • 50 institutional investors held EnteroMedics Inc. (ETRM) as of Q4 2013, up from 42 in Q3 2013.
  • Funds reported $45.9M of EnteroMedics Inc. stock for Q4 2013, up 100% quarter-over-quarter.
  • 17 funds opened new EnteroMedics Inc. positions in Q4 2013 and 9 closed out, a net change of +8 holders.
  • The largest EnteroMedics Inc. buyer in Q4 2013 was Royce & Associates, an estimated $1.92M added.
  • The largest EnteroMedics Inc. seller in Q4 2013 was Wells Fargo, an estimated $625K sold.

Based on aggregated 13F filings for Q4 2013.